Type 1 diabetes (T1D) is an autoimmune disease that occurs when a person?s pancreas stops producing insulin, the hormone that controls blood-sugar levels. T1D develops when the insulin-producing pancreatic beta cells are mistakenly destroyed by the body?s immune system. The cause of this attack is still being researched, however scientists believe the cause may have genetic and environmental components.
This report aims to provide a comprehensive presentation of the global market for Type 1 Diabetes (T1D), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Type 1 Diabetes (T1D). This report contains market size and forecasts of Type 1 Diabetes (T1D) in global, including the following market information:
Global Type 1 Diabetes (T1D) Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Type 1 Diabetes (T1D) Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Type 1 Diabetes (T1D) companies in 2022 (%)
The global Type 1 Diabetes (T1D) market was valued at US$ 1956.2 million in 2022 and is projected to reach US$ 2644.8 million by 2029, at a CAGR of 4.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Sedentary lifestyle, unhealthy diet, lack of exercise and increasing prevalence of diabetes are key driver for Type 1 Diabetes (T1D) market. Insulin therapy is very much essential in the patients who have type 1 diabetes. Rising launch of the novel insulin formulations along with several adjunct therapies will positively impact the insulin acceptance. On the other hand, this chronic disorder poses a significant economic impact owing to the increasing cost of insulin coupled with other conditions such as cardiac disorders, kidney disease among others. While insulin therapy keeps people with T1D alive and can help keep blood-glucose levels within recommended range, it is not a cure, nor does it prevent the possibility of T1D?s serious effects. Although T1D is a serious and challenging disease, long-term management options continue to evolve, allowing those with T1D to have full and active lives. Asia Pacific region recorded the highest growth rate over the forecast period owing to the increasingly sedentary lifestyles, obese population, and improper food habits. North America accounted for more than 50% of the total market share over the forecast period.
We surveyed the Type 1 Diabetes (T1D) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Type 1 Diabetes (T1D) Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Type 1 Diabetes (T1D) Market Segment Percentages, by Type, 2022 (%)
Rapid Acting Insulin Analogs
Long Acting Insulin Analogs
Premix Insulin Analogs
Global Type 1 Diabetes (T1D) Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Type 1 Diabetes (T1D) Market Segment Percentages, by Application, 2022 (%)
Children
Adults
Global Type 1 Diabetes (T1D) Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Type 1 Diabetes (T1D) Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Type 1 Diabetes (T1D) revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Type 1 Diabetes (T1D) revenues share in global market, 2022 (%)
Key companies Type 1 Diabetes (T1D) sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Type 1 Diabetes (T1D) sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novo Nordisk
Sanofi
Eli Lilly
Merck
Boehringer Ingelheim
Samsung Bioepis
Biocon
Astellas
Janssen
Bristol-Myers Squibb
Lexicon
Sanofi
Outline of Major Chapters:
Chapter 1: Introduces the definition of Type 1 Diabetes (T1D), market overview.
Chapter 2: Global Type 1 Diabetes (T1D) market size in revenue and volume.
Chapter 3: Detailed analysis of Type 1 Diabetes (T1D) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Type 1 Diabetes (T1D) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Type 1 Diabetes (T1D) capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Type 1 Diabetes (T1D) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Type 1 Diabetes (T1D) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Type 1 Diabetes (T1D) Overall Market Size
2.1 Global Type 1 Diabetes (T1D) Market Size: 2022 VS 2029
2.2 Global Type 1 Diabetes (T1D) Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Type 1 Diabetes (T1D) Sales: 2018-2029
3 Company Landscape
3.1 Top Type 1 Diabetes (T1D) Players in Global Market
3.2 Top Global Type 1 Diabetes (T1D) Companies Ranked by Revenue
3.3 Global Type 1 Diabetes (T1D) Revenue by Companies
3.4 Global Type 1 Diabetes (T1D) Sales by Companies
3.5 Global Type 1 Diabetes (T1D) Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Type 1 Diabetes (T1D) Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Type 1 Diabetes (T1D) Product Type
3.8 Tier 1, Tier 2 and Tier 3 Type 1 Diabetes (T1D) Players in Global Market
3.8.1 List of Global Tier 1 Type 1 Diabetes (T1D) Companies
3.8.2 List of Global Tier 2 and Tier 3 Type 1 Diabetes (T1D) Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Type 1 Diabetes (T1D) Market Size Markets, 2022 & 2029
4.1.2 Rapid Acting Insulin Analogs
4.1.3 Long Acting Insulin Analogs
4.1.4 Premix Insulin Analogs
4.2 By Type - Global Type 1 Diabetes (T1D) Revenue & Forecasts
4.2.1 By Type - Global Type 1 Diabetes (T1D) Revenue, 2018-2023
4.2.2 By Type - Global Type 1 Diabetes (T1D) Revenue, 2024-2029
4.2.3 By Type - Global Type 1 Diabetes (T1D) Revenue Market Share, 2018-2029
4.3 By Type - Global Type 1 Diabetes (T1D) Sales & Forecasts
4.3.1 By Type - Global Type 1 Diabetes (T1D) Sales, 2018-2023
4.3.2 By Type - Global Type 1 Diabetes (T1D) Sales, 2024-2029
4.3.3 By Type - Global Type 1 Diabetes (T1D) Sales Market Share, 2018-2029
4.4 By Type - Global Type 1 Diabetes (T1D) Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Type 1 Diabetes (T1D) Market Size, 2022 & 2029
5.1.2 Children
5.1.3 Adults
5.2 By Application - Global Type 1 Diabetes (T1D) Revenue & Forecasts
5.2.1 By Application - Global Type 1 Diabetes (T1D) Revenue, 2018-2023
5.2.2 By Application - Global Type 1 Diabetes (T1D) Revenue, 2024-2029
5.2.3 By Application - Global Type 1 Diabetes (T1D) Revenue Market Share, 2018-2029
5.3 By Application - Global Type 1 Diabetes (T1D) Sales & Forecasts
5.3.1 By Application - Global Type 1 Diabetes (T1D) Sales, 2018-2023
5.3.2 By Application - Global Type 1 Diabetes (T1D) Sales, 2024-2029
5.3.3 By Application - Global Type 1 Diabetes (T1D) Sales Market Share, 2018-2029
5.4 By Application - Global Type 1 Diabetes (T1D) Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Type 1 Diabetes (T1D) Market Size, 2022 & 2029
6.2 By Region - Global Type 1 Diabetes (T1D) Revenue & Forecasts
6.2.1 By Region - Global Type 1 Diabetes (T1D) Revenue, 2018-2023
6.2.2 By Region - Global Type 1 Diabetes (T1D) Revenue, 2024-2029
6.2.3 By Region - Global Type 1 Diabetes (T1D) Revenue Market Share, 2018-2029
6.3 By Region - Global Type 1 Diabetes (T1D) Sales & Forecasts
6.3.1 By Region - Global Type 1 Diabetes (T1D) Sales, 2018-2023
6.3.2 By Region - Global Type 1 Diabetes (T1D) Sales, 2024-2029
6.3.3 By Region - Global Type 1 Diabetes (T1D) Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Type 1 Diabetes (T1D) Revenue, 2018-2029
6.4.2 By Country - North America Type 1 Diabetes (T1D) Sales, 2018-2029
6.4.3 US Type 1 Diabetes (T1D) Market Size, 2018-2029
6.4.4 Canada Type 1 Diabetes (T1D) Market Size, 2018-2029
6.4.5 Mexico Type 1 Diabetes (T1D) Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Type 1 Diabetes (T1D) Revenue, 2018-2029
6.5.2 By Country - Europe Type 1 Diabetes (T1D) Sales, 2018-2029
6.5.3 Germany Type 1 Diabetes (T1D) Market Size, 2018-2029
6.5.4 France Type 1 Diabetes (T1D) Market Size, 2018-2029
6.5.5 U.K. Type 1 Diabetes (T1D) Market Size, 2018-2029
6.5.6 Italy Type 1 Diabetes (T1D) Market Size, 2018-2029
6.5.7 Russia Type 1 Diabetes (T1D) Market Size, 2018-2029
6.5.8 Nordic Countries Type 1 Diabetes (T1D) Market Size, 2018-2029
6.5.9 Benelux Type 1 Diabetes (T1D) Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Type 1 Diabetes (T1D) Revenue, 2018-2029
6.6.2 By Region - Asia Type 1 Diabetes (T1D) Sales, 2018-2029
6.6.3 China Type 1 Diabetes (T1D) Market Size, 2018-2029
6.6.4 Japan Type 1 Diabetes (T1D) Market Size, 2018-2029
6.6.5 South Korea Type 1 Diabetes (T1D) Market Size, 2018-2029
6.6.6 Southeast Asia Type 1 Diabetes (T1D) Market Size, 2018-2029
6.6.7 India Type 1 Diabetes (T1D) Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Type 1 Diabetes (T1D) Revenue, 2018-2029
6.7.2 By Country - South America Type 1 Diabetes (T1D) Sales, 2018-2029
6.7.3 Brazil Type 1 Diabetes (T1D) Market Size, 2018-2029
6.7.4 Argentina Type 1 Diabetes (T1D) Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Type 1 Diabetes (T1D) Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Type 1 Diabetes (T1D) Sales, 2018-2029
6.8.3 Turkey Type 1 Diabetes (T1D) Market Size, 2018-2029
6.8.4 Israel Type 1 Diabetes (T1D) Market Size, 2018-2029
6.8.5 Saudi Arabia Type 1 Diabetes (T1D) Market Size, 2018-2029
6.8.6 UAE Type 1 Diabetes (T1D) Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Novo Nordisk
7.1.1 Novo Nordisk Company Summary
7.1.2 Novo Nordisk Business Overview
7.1.3 Novo Nordisk Type 1 Diabetes (T1D) Major Product Offerings
7.1.4 Novo Nordisk Type 1 Diabetes (T1D) Sales and Revenue in Global (2018-2023)
7.1.5 Novo Nordisk Key News & Latest Developments
7.2 Sanofi
7.2.1 Sanofi Company Summary
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Type 1 Diabetes (T1D) Major Product Offerings
7.2.4 Sanofi Type 1 Diabetes (T1D) Sales and Revenue in Global (2018-2023)
7.2.5 Sanofi Key News & Latest Developments
7.3 Eli Lilly
7.3.1 Eli Lilly Company Summary
7.3.2 Eli Lilly Business Overview
7.3.3 Eli Lilly Type 1 Diabetes (T1D) Major Product Offerings
7.3.4 Eli Lilly Type 1 Diabetes (T1D) Sales and Revenue in Global (2018-2023)
7.3.5 Eli Lilly Key News & Latest Developments
7.4 Merck
7.4.1 Merck Company Summary
7.4.2 Merck Business Overview
7.4.3 Merck Type 1 Diabetes (T1D) Major Product Offerings
7.4.4 Merck Type 1 Diabetes (T1D) Sales and Revenue in Global (2018-2023)
7.4.5 Merck Key News & Latest Developments
7.5 Boehringer Ingelheim
7.5.1 Boehringer Ingelheim Company Summary
7.5.2 Boehringer Ingelheim Business Overview
7.5.3 Boehringer Ingelheim Type 1 Diabetes (T1D) Major Product Offerings
7.5.4 Boehringer Ingelheim Type 1 Diabetes (T1D) Sales and Revenue in Global (2018-2023)
7.5.5 Boehringer Ingelheim Key News & Latest Developments
7.6 Samsung Bioepis
7.6.1 Samsung Bioepis Company Summary
7.6.2 Samsung Bioepis Business Overview
7.6.3 Samsung Bioepis Type 1 Diabetes (T1D) Major Product Offerings
7.6.4 Samsung Bioepis Type 1 Diabetes (T1D) Sales and Revenue in Global (2018-2023)
7.6.5 Samsung Bioepis Key News & Latest Developments
7.7 Biocon
7.7.1 Biocon Company Summary
7.7.2 Biocon Business Overview
7.7.3 Biocon Type 1 Diabetes (T1D) Major Product Offerings
7.7.4 Biocon Type 1 Diabetes (T1D) Sales and Revenue in Global (2018-2023)
7.7.5 Biocon Key News & Latest Developments
7.8 Astellas
7.8.1 Astellas Company Summary
7.8.2 Astellas Business Overview
7.8.3 Astellas Type 1 Diabetes (T1D) Major Product Offerings
7.8.4 Astellas Type 1 Diabetes (T1D) Sales and Revenue in Global (2018-2023)
7.8.5 Astellas Key News & Latest Developments
7.9 Janssen
7.9.1 Janssen Company Summary
7.9.2 Janssen Business Overview
7.9.3 Janssen Type 1 Diabetes (T1D) Major Product Offerings
7.9.4 Janssen Type 1 Diabetes (T1D) Sales and Revenue in Global (2018-2023)
7.9.5 Janssen Key News & Latest Developments
7.10 Bristol-Myers Squibb
7.10.1 Bristol-Myers Squibb Company Summary
7.10.2 Bristol-Myers Squibb Business Overview
7.10.3 Bristol-Myers Squibb Type 1 Diabetes (T1D) Major Product Offerings
7.10.4 Bristol-Myers Squibb Type 1 Diabetes (T1D) Sales and Revenue in Global (2018-2023)
7.10.5 Bristol-Myers Squibb Key News & Latest Developments
7.11 Lexicon
7.11.1 Lexicon Company Summary
7.11.2 Lexicon Type 1 Diabetes (T1D) Business Overview
7.11.3 Lexicon Type 1 Diabetes (T1D) Major Product Offerings
7.11.4 Lexicon Type 1 Diabetes (T1D) Sales and Revenue in Global (2018-2023)
7.11.5 Lexicon Key News & Latest Developments
7.12 Sanofi
7.12.1 Sanofi Company Summary
7.12.2 Sanofi Type 1 Diabetes (T1D) Business Overview
7.12.3 Sanofi Type 1 Diabetes (T1D) Major Product Offerings
7.12.4 Sanofi Type 1 Diabetes (T1D) Sales and Revenue in Global (2018-2023)
7.12.5 Sanofi Key News & Latest Developments
8 Global Type 1 Diabetes (T1D) Production Capacity, Analysis
8.1 Global Type 1 Diabetes (T1D) Production Capacity, 2018-2029
8.2 Type 1 Diabetes (T1D) Production Capacity of Key Manufacturers in Global Market
8.3 Global Type 1 Diabetes (T1D) Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Type 1 Diabetes (T1D) Supply Chain Analysis
10.1 Type 1 Diabetes (T1D) Industry Value Chain
10.2 Type 1 Diabetes (T1D) Upstream Market
10.3 Type 1 Diabetes (T1D) Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Type 1 Diabetes (T1D) Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Type 1 Diabetes (T1D) in Global Market
Table 2. Top Type 1 Diabetes (T1D) Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Type 1 Diabetes (T1D) Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Type 1 Diabetes (T1D) Revenue Share by Companies, 2018-2023
Table 5. Global Type 1 Diabetes (T1D) Sales by Companies, (K Units), 2018-2023
Table 6. Global Type 1 Diabetes (T1D) Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Type 1 Diabetes (T1D) Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Type 1 Diabetes (T1D) Product Type
Table 9. List of Global Tier 1 Type 1 Diabetes (T1D) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Type 1 Diabetes (T1D) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Type 1 Diabetes (T1D) Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Type 1 Diabetes (T1D) Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Type 1 Diabetes (T1D) Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Type 1 Diabetes (T1D) Sales (K Units), 2018-2023
Table 15. By Type - Global Type 1 Diabetes (T1D) Sales (K Units), 2024-2029
Table 16. By Application ? Global Type 1 Diabetes (T1D) Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Type 1 Diabetes (T1D) Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Type 1 Diabetes (T1D) Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Type 1 Diabetes (T1D) Sales (K Units), 2018-2023
Table 20. By Application - Global Type 1 Diabetes (T1D) Sales (K Units), 2024-2029
Table 21. By Region ? Global Type 1 Diabetes (T1D) Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Type 1 Diabetes (T1D) Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Type 1 Diabetes (T1D) Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Type 1 Diabetes (T1D) Sales (K Units), 2018-2023
Table 25. By Region - Global Type 1 Diabetes (T1D) Sales (K Units), 2024-2029
Table 26. By Country - North America Type 1 Diabetes (T1D) Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Type 1 Diabetes (T1D) Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Type 1 Diabetes (T1D) Sales, (K Units), 2018-2023
Table 29. By Country - North America Type 1 Diabetes (T1D) Sales, (K Units), 2024-2029
Table 30. By Country - Europe Type 1 Diabetes (T1D) Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Type 1 Diabetes (T1D) Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Type 1 Diabetes (T1D) Sales, (K Units), 2018-2023
Table 33. By Country - Europe Type 1 Diabetes (T1D) Sales, (K Units), 2024-2029
Table 34. By Region - Asia Type 1 Diabetes (T1D) Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Type 1 Diabetes (T1D) Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Type 1 Diabetes (T1D) Sales, (K Units), 2018-2023
Table 37. By Region - Asia Type 1 Diabetes (T1D) Sales, (K Units), 2024-2029
Table 38. By Country - South America Type 1 Diabetes (T1D) Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Type 1 Diabetes (T1D) Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Type 1 Diabetes (T1D) Sales, (K Units), 2018-2023
Table 41. By Country - South America Type 1 Diabetes (T1D) Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Type 1 Diabetes (T1D) Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Type 1 Diabetes (T1D) Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Type 1 Diabetes (T1D) Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Type 1 Diabetes (T1D) Sales, (K Units), 2024-2029
Table 46. Novo Nordisk Company Summary
Table 47. Novo Nordisk Type 1 Diabetes (T1D) Product Offerings
Table 48. Novo Nordisk Type 1 Diabetes (T1D) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Novo Nordisk Key News & Latest Developments
Table 50. Sanofi Company Summary
Table 51. Sanofi Type 1 Diabetes (T1D) Product Offerings
Table 52. Sanofi Type 1 Diabetes (T1D) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Sanofi Key News & Latest Developments
Table 54. Eli Lilly Company Summary
Table 55. Eli Lilly Type 1 Diabetes (T1D) Product Offerings
Table 56. Eli Lilly Type 1 Diabetes (T1D) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Eli Lilly Key News & Latest Developments
Table 58. Merck Company Summary
Table 59. Merck Type 1 Diabetes (T1D) Product Offerings
Table 60. Merck Type 1 Diabetes (T1D) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Merck Key News & Latest Developments
Table 62. Boehringer Ingelheim Company Summary
Table 63. Boehringer Ingelheim Type 1 Diabetes (T1D) Product Offerings
Table 64. Boehringer Ingelheim Type 1 Diabetes (T1D) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Boehringer Ingelheim Key News & Latest Developments
Table 66. Samsung Bioepis Company Summary
Table 67. Samsung Bioepis Type 1 Diabetes (T1D) Product Offerings
Table 68. Samsung Bioepis Type 1 Diabetes (T1D) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Samsung Bioepis Key News & Latest Developments
Table 70. Biocon Company Summary
Table 71. Biocon Type 1 Diabetes (T1D) Product Offerings
Table 72. Biocon Type 1 Diabetes (T1D) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Biocon Key News & Latest Developments
Table 74. Astellas Company Summary
Table 75. Astellas Type 1 Diabetes (T1D) Product Offerings
Table 76. Astellas Type 1 Diabetes (T1D) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Astellas Key News & Latest Developments
Table 78. Janssen Company Summary
Table 79. Janssen Type 1 Diabetes (T1D) Product Offerings
Table 80. Janssen Type 1 Diabetes (T1D) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Janssen Key News & Latest Developments
Table 82. Bristol-Myers Squibb Company Summary
Table 83. Bristol-Myers Squibb Type 1 Diabetes (T1D) Product Offerings
Table 84. Bristol-Myers Squibb Type 1 Diabetes (T1D) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Bristol-Myers Squibb Key News & Latest Developments
Table 86. Lexicon Company Summary
Table 87. Lexicon Type 1 Diabetes (T1D) Product Offerings
Table 88. Lexicon Type 1 Diabetes (T1D) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 89. Lexicon Key News & Latest Developments
Table 90. Sanofi Company Summary
Table 91. Sanofi Type 1 Diabetes (T1D) Product Offerings
Table 92. Sanofi Type 1 Diabetes (T1D) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 93. Sanofi Key News & Latest Developments
Table 94. Type 1 Diabetes (T1D) Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 95. Global Type 1 Diabetes (T1D) Capacity Market Share of Key Manufacturers, 2021-2023
Table 96. Global Type 1 Diabetes (T1D) Production by Region, 2018-2023 (K Units)
Table 97. Global Type 1 Diabetes (T1D) Production by Region, 2024-2029 (K Units)
Table 98. Type 1 Diabetes (T1D) Market Opportunities & Trends in Global Market
Table 99. Type 1 Diabetes (T1D) Market Drivers in Global Market
Table 100. Type 1 Diabetes (T1D) Market Restraints in Global Market
Table 101. Type 1 Diabetes (T1D) Raw Materials
Table 102. Type 1 Diabetes (T1D) Raw Materials Suppliers in Global Market
Table 103. Typical Type 1 Diabetes (T1D) Downstream
Table 104. Type 1 Diabetes (T1D) Downstream Clients in Global Market
Table 105. Type 1 Diabetes (T1D) Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Type 1 Diabetes (T1D) Segment by Type in 2022
Figure 2. Type 1 Diabetes (T1D) Segment by Application in 2022
Figure 3. Global Type 1 Diabetes (T1D) Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Type 1 Diabetes (T1D) Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Type 1 Diabetes (T1D) Revenue, 2018-2029 (US$, Mn)
Figure 7. Type 1 Diabetes (T1D) Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Type 1 Diabetes (T1D) Revenue in 2022
Figure 9. By Type - Global Type 1 Diabetes (T1D) Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Type 1 Diabetes (T1D) Revenue Market Share, 2018-2029
Figure 11. By Type - Global Type 1 Diabetes (T1D) Sales Market Share, 2018-2029
Figure 12. By Type - Global Type 1 Diabetes (T1D) Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Type 1 Diabetes (T1D) Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Type 1 Diabetes (T1D) Revenue Market Share, 2018-2029
Figure 15. By Application - Global Type 1 Diabetes (T1D) Sales Market Share, 2018-2029
Figure 16. By Application - Global Type 1 Diabetes (T1D) Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Type 1 Diabetes (T1D) Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Type 1 Diabetes (T1D) Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Type 1 Diabetes (T1D) Revenue Market Share, 2018-2029
Figure 20. By Region - Global Type 1 Diabetes (T1D) Sales Market Share, 2018-2029
Figure 21. By Country - North America Type 1 Diabetes (T1D) Revenue Market Share, 2018-2029
Figure 22. By Country - North America Type 1 Diabetes (T1D) Sales Market Share, 2018-2029
Figure 23. US Type 1 Diabetes (T1D) Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Type 1 Diabetes (T1D) Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Type 1 Diabetes (T1D) Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Type 1 Diabetes (T1D) Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Type 1 Diabetes (T1D) Sales Market Share, 2018-2029
Figure 28. Germany Type 1 Diabetes (T1D) Revenue, (US$, Mn), 2018-2029
Figure 29. France Type 1 Diabetes (T1D) Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Type 1 Diabetes (T1D) Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Type 1 Diabetes (T1D) Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Type 1 Diabetes (T1D) Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Type 1 Diabetes (T1D) Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Type 1 Diabetes (T1D) Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Type 1 Diabetes (T1D) Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Type 1 Diabetes (T1D) Sales Market Share, 2018-2029
Figure 37. China Type 1 Diabetes (T1D) Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Type 1 Diabetes (T1D) Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Type 1 Diabetes (T1D) Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Type 1 Diabetes (T1D) Revenue, (US$, Mn), 2018-2029
Figure 41. India Type 1 Diabetes (T1D) Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Type 1 Diabetes (T1D) Revenue Market Share, 2018-2029
Figure 43. By Country - South America Type 1 Diabetes (T1D) Sales Market Share, 2018-2029
Figure 44. Brazil Type 1 Diabetes (T1D) Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Type 1 Diabetes (T1D) Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Type 1 Diabetes (T1D) Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Type 1 Diabetes (T1D) Sales Market Share, 2018-2029
Figure 48. Turkey Type 1 Diabetes (T1D) Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Type 1 Diabetes (T1D) Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Type 1 Diabetes (T1D) Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Type 1 Diabetes (T1D) Revenue, (US$, Mn), 2018-2029
Figure 52. Global Type 1 Diabetes (T1D) Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Type 1 Diabetes (T1D) by Region, 2022 VS 2029
Figure 54. Type 1 Diabetes (T1D) Industry Value Chain
Figure 55. Marketing Channels
